DOI: 10.3724/SP.J.1263.2012.08141

Journal of Geriatric Cardiology 2012/9:4 PP.379-388

Atrial fibrillation in the elderly: the potential contribution of reactive oxygen species

Atrial fibrillation (AF) is the most commonly encountered cardiac arrhythmia, and is a significant source of healthcare expenditures throughout the world. It is an arrhythmia with a very clearly defined predisposition for individuals of advanced age, and this fact has led to intense study of the mechanistic links between aging and AF. By promoting oxidative damage to multiple subcellular and cellular structures, reactive oxygen species (ROS) have been shown to induce the intra- and extra-cellular changes necessary to promote the pathogenesis of AF. In addition, the generation and accumulation of ROS have been intimately linked to the cellular processes which underlie aging. This review begins with an overview of AF pathophysiology, and introduces the critical structures which, when damaged, predispose an otherwise healthy atrium to AF. The available evidence that ROS can lead to damage of these critical structures is then reviewed. Finally, the evidence linking the process of aging to the pathogenesis of AF is discussed.

Key words:Arrhythmia,Cardiac,Atrial fibrillation,Aging,Redox,Free radicals,Oxidative stress

ReleaseDate:2014-07-21 16:32:16

1 Naccarelli GV, Varker H, Lin J, et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009; 104: 1534-1539.

2 Davis RC, Hobbs FDR, Kenkre JE, et al. Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. Europace 2012; [Epub ahead of print]. Available from:

3 Kim MH, Johnston SS, Chu BC, et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 2011; 4: 313-320.

4 Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82(8A): 2N-9N.

5 Jackson MJ, McArdle A. Age-related changes in skeletal muscle reactive oxygen species generation and adaptive responses to reactive oxygen species. J Physiol (Lond) 2011; 589 (Pt 9): 2139-2145.

6 Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008; 1: 62-73.

7 Patel VV. Novel insights into the cellular basis of atrial fibrilation. Expert Rev Cardiovasc Ther 2010; 8: 907-916.

8 Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002; 415: 219-226.

9 Iwasaki Y, Nishida K, Kato T, et al. Atrial fibrillation pathophysiology: implications for management. Circulation 2011; 124: 2264-2274.

10 Stillitano F, Lonardo G, Zicha S, et al. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol 2008; 45: 289-299.

11 Dhamoon AS, Jalife J. The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis. Heart Rhythm 2005; 2: 316-324.

12 Zhao Z, Xie Y, Wen H, et al. Role of the transient outward potassium current in the genesis of early afterdepolarizations in cardiac cells. Cardiovasc Res 2012; 95: 308-316.

13 Voigt N, Li N, Wang Q, et al. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 2012; 125: 2059-2070.

14 Fink M, Noble PJ, Noble D. Ca2+-induced delayed afterdepo-larizations are triggered by dyadic subspace Ca22+ affirming that increasing SERCA reduces aftercontractions. Am J Physiol Heart Circ Physiol 2011; 301: 921-935.

15 Perez-Lugones A, McMahon JT, Ratliff NB, et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol 2003; 14: 803-809.

16 Chou CC, Nihei M, Zhou S, et al. Intracellular calcium dynamics and anisotropic reentry in isolated canine pulmonary veins and left atrium. Circulation 2005; 111: 2889-2897.

17 Morel E, Meyronet D, Thivolet-Bejuy F, et al. Identification and distribution of interstitial Cajal cells in human pulmonary veins. Heart Rhythm 2008; 5: 1063-1067.

18 Gherghiceanu M, Hinescu ME, Andrei F, et al. Interstitial Cajal-like cells (ICLC) in myocardial sleeves of human pulmonary veins. J Cell Mol Med 2008; 12: 1777-1781.

19 Chen YJ, Chen SA. Electrophysiology of pulmonary veins. J Cardiovasc Electrophysiol 2006; 17: 220-224.

20 Yu MC, Huang CF, Chang CM, et al. Diverse cell morphology and intracellular calcium dynamics in pulmonary vein cardiomyocytes. Heart Vessels 2011; 26: 101-110.

21 Wongcharoen W, Chen YC, Chen YJ, et al. Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity. Cardiovasc Res 2006; 70: 497-508.

22 Levin MD, Lu MM, Petrenko NB, et al. Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers. J Clin Invest 2009; 119: 3420-3436.

23 Mommersteeg MTM, Christoffels VM, Anderson RH, et al. Atrial fibrillation: a developmental point of view. Heart Rhythm 2009; 6: 1818-1824.

24 Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.

25 Chen YJ, Chen SA, Chen YC, et al. Electrophysiology of single cardiomyocytes isolated from rabbit pulmonary veins: implication in initiation of focal atrial fibrillation. Basic Res Cardiol 2002; 97: 26-34.

26 Honjo H, Boyett MR, Niwa R, et al. Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine. Circulation 2003; 107: 1937-1943.

27 Ehrlich JR, Cha TJ, Zhang L, et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J Physiol (Lond) 2003; 551(Pt 3): 801-813.

28 Kostin S. Myocardial telocytes: a specific new cellular entity. J Cell Mol Med 2010; 14: 1917-1921.

29 Hillock RJ, Kalman JM, Roberts-Thomson KC, et al. Multiple focal atrial tachycardias in a healthy adult population: characterization and description of successful radiofrequency ablation. Heart Rhythm 2007; 4: 435-438.

30 Kistler PM, Sanders P, Hussin A, et al. Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J Am Coll Cardiol 2003; 41: 2212-2219.

31 Hirst GDS, Edwards FR. Electrical events underlying organized myogenic contractions of the guinea pig stomach. J Physiol (Lond) 2006; 576(Pt 3): 659-665.

32 Greiser M, Lederer WJ, Schotten U. Alterations of atrial Ca (2+) handling as cause and consequence of atrial fibrillation. Cardiovasc Res 2011; 89: 722-733.

33 Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J 2012; 33: 1870-1877.

34 Goudis CA, Kallergis EM, Vardas PE. Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation. Europace 2012; 14: 623-630.

35 Friedrichs K, Baldus S, Klinke A. Fibrosis in atrial fibrillation-Role of reactive species and MPO. Front Physiol 2012; 3: 214.

36 Bonilla IM, Sridhar A, Györke S, et al. Nitric oxide synthases and atrial fibrillation. Front Physiol 2012; 3: 105.

37 Reilly SN, Jayaram R, Nahar K, et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 2011; 124: 1107-1117.

38 Kim YM, Guzik TJ, Zhang YH, et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005; 97: 629-636.

39 Nishijima Y, Sridhar A, Bonilla I, et al. Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res 2011; 91: 71-79.

40 Shiroshita-Takeshita A, Brundel BJJM, Lavoie J, et al. Prednisone prevents atrial fibrillation promotion by atrial tachy-cardia remodeling in dogs. Cardiovasc Res 2006; 69: 865-875.

41 Rudolph V, Andrié RP, Rudolph TK, et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 2010; 16: 470-474.

42 Richter B, Gwechenberger M, Socas A, et al. Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol 2012; 101: 217-225.

43 Kolbe K, Schönherr R, Gessner G, et al. Cysteine 723 in the C-linker segment confers oxidative inhibition of hERG1 potassium channels. J Physiol (Lond) 2010; 588(Pt 16): 2999-3009.

44 Wang X, Takeda S, Mochizuki S, et al. Mechanisms of hydrogen peroxide-induced increase in intracellular calcium in cardiomyocytes. J Cardiovasc Pharmacol Ther 1999; 4: 41-48.

45 Wagoner DR Van. Redox modulation of cardiac electrical activity. J Cardiovasc Electrophysiol 2001; 12: 183-184.

46 Bérubé J, Caouette D, Daleau P. Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line. J Pharmacol Exp Ther 2001; 297: 96-102.

47 Corretti MC, Koretsune Y, Kusuoka H, et al. Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts. J Clin Invest 1991; 88: 1014-1025.

48 Ward CA, Giles WR. Ionic mechanism of the effects of hydro-gen peroxide in rat ventricular myocytes. J Physiol (Lond) 1997; 500 (Pt 3): 631-642.

49 Song Y, Shryock JC, Wagner S, et al. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 2006; 318: 214-222.

50 Barrington PL, Meier CF Jr., Weglicki WB. Abnormal electrical activity induced by H2O2 in isolated canine myocytes. Basic Life Sci 1988; 49: 927-932.

51 Lin YK, Lin FZ, Chen YC, et al. Oxidative stress on pulmo- nary vein and left atrium arrhythmogenesis. Circ J 2010; 74: 1547-1556.

52 Goldhaber JI. Free radicals enhance Na+/Ca2+ exchange in ventricular myocytes. Am J Physiol 1996; 271(3 Pt 2): H823-H833.

53 Hinata M, Matsuoka I, Iwamoto T, et al. Mechanism of Na+/Ca2+ exchanger activation by hydrogen peroxide in guinea-pig ventricular myocytes. J Pharmacol Sci 2007; 103: 283-292.

54 Morris TE, Sulakhe PV. Sarcoplasmic reticulum Ca(2+)-pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals. Free Radic. Biol. Med. 1997; 22(1-2): 37-47.

55 Zissimopoulos S, Docrat N, Lai FA. Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. J Biol Chem 2007; 282: 6976-6983.

56 Anzai K, Ogawa K, Ozawa T, et al. Oxidative modification of ion channel activity of ryanodine receptor. Antioxid. Redox Signal 2000; 2: 35-40.

57 Goldhaber JI, Liu E. Excitation-contraction coupling in single guinea-pig ventricular myocytes exposed to hydrogen peroxide. J Physiol (Lond) 1994; 477 (Pt 1): 135-147.

58 Hudasek K, Brown ST, Fearon IM. H2O2 regulates recombinant Ca2+ channel alpha1C subunits but does not mediate their sensitivity to acute hypoxia. Biochem Biophys Res Commun 2004; 318: 135-141.

59 Guo J, Giles WR, Ward CA. Effect of hydrogen peroxide on the membrane currents of sinoatrial node cells from rabbit heart. Am J Physiol Heart Circ Physiol 2000; 279: H992-H999.

60 Spallarossa P, Altieri P, Garibaldi S, et al. Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase. Cardiovasc Res 2006; 69: 736-745.

61 Zhao W, Zhao T, Chen Y, et al. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem 2008; 317: 43-50.

62 Navarro A, Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 2007; 292: 670-686.

63 Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005; 120: 483-495.

64 Dai DF, Rabinovitch PS. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med 2009; 19: 213-220.

65 Wongcharoen W, Chen YC, Chen YJ, et al. Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents. Heart Rhythm 2007; 4: 1338-1349.

66 Xu D, Murakoshi N, Igarashi M, et al. PPAR-γ activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model. J Cardiovasc Electrophysiol 2012; 23: 209-217.

67 Platonov PG, Mitrofanova LB, Orshanskaya V, et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 2011; 58: 2225-2232.

68 Gu WJ, Wu ZJ, Wang PF, et al. N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovasc Disord 2012; 12: 10.

69 Karimi A, Bidhendi LM, Rezvanfard M, et al. The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2012; 94: 8-14.

70 Wongcharoen W, Chen YC, Chen YJ, et al. Effects of aging and ouabain on left atrial arrhythmogenicity. J Cardiovasc Elec-trophysiol 2007; 18: 526-531.

71 Brorson L, Olsson SB. Right atrial monophasic action potential in healthy males. Studies during spontaneous sinus rhythm and atrial pacing. Acta Med Scand 1976; 199: 433-446.

72 Fox CS, Parise H, D’Agostino RB Sr, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004; 291: 2851-2855.

73 Arnar DO, Thorvaldsson S, Manolio TA. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 2006; 27: 708-712.

74 Ellinor PT, Lunetta KL, Albert CM, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012; 44: 670-675.

75 Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/ HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm 2011; 8: 157-176.